{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T08:54:05Z","timestamp":1791881645951,"version":"4.3.4"},"reference-count":34,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background\/Objectives: We aim to synthesize recent clinical and translational evidence on the relationship between endometriosis and ovarian cancer, with emphasis on publications from 2024 to 2026 and on clinically conservative risk stratification. Materials and Methods: This state-of-the-art narrative review prioritizes major peer-reviewed publications from July 2024 to June 2026. Older landmark publications were used only where necessary to contextualize recent findings. Results: Recent evidence supports a selective, phenotype-dependent association instead of a generalized malignant potential of endometriosis. The strongest and most reproducible signal concerns epithelial ovarian cancer, especially clear-cell and endometrioid ovarian carcinoma, with the highest relative risks reported for ovarian endometrioma and\/or deep endometriosis. The ENDOCANCER meta-analysis found increased ovarian cancer risk across odds ratio, hazard ratio and standardized incidence ratio estimates but confirmed low absolute incidence and substantial heterogeneity. Contemporary reviews, including Leone Roberti Maggiore et al. and Bogani et al., emphasize low absolute lifetime risk and the absence of evidence supporting universal oncologic surveillance. Newer clinicopathological studies distinguish endometriosis-correlated tumors supported by transitional lesions indicative of malignant transformation from incidental coexistence. Molecular data support biological plausibility through ARID1A, PIK3CA, KRAS, PTEN, mismatch repair deficiency, POLE-mutated disease and p53-abnormal phenotypes, but these markers are not ready for routine prediction in endometriosis care. Conclusions: The immediate clinical implication is individualized risk assessment in place of routine cancer screening or prophylactic surgery based solely on the increased cancer risk associated with endometriosis. Counseling should integrate endometriosis phenotype, age, menopausal status, lesion dynamics, imaging atypia, hereditary cancer risk, reproductive goals and surgical consequences.<\/jats:p>","DOI":"10.3390\/cancers18193241","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:16:52Z","timestamp":1791472612000},"page":"3241","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Recent Developments in Studies on the Relation Between Endometriosis and Ovarian Cancer: Phenotype-Specific Risk, Molecular Convergence and Clinical Risk Stratification"],"prefix":"10.3390","volume":"18","author":[{"given":"Klaudia","family":"Gutowska","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Institute of Mother and Child, 01-211 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6729-7469","authenticated-orcid":false,"given":"Aleksandra","family":"Urban","sequence":"additional","affiliation":[{"name":"2nd Department of Obstetrics and Gynecology, Medical University of Warsaw, 02-091 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cezary","family":"Wojty\u0142a","sequence":"additional","affiliation":[{"name":"Women\u2019s Health Research Institute, Calisia University, 62-800 Kalisz, Poland"},{"name":"OVIklinika Infertility Center, 01-377 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u0142awomir","family":"\u0141awicki","sequence":"additional","affiliation":[{"name":"Department of Population Medicine and Lifestyle Diseases Prevention, University of Bia\u0142ystok, 15-269 Bia\u0142ystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8955-8198","authenticated-orcid":false,"given":"Piotr","family":"Lauda\u0144ski","sequence":"additional","affiliation":[{"name":"Women\u2019s Health Research Institute, Calisia University, 62-800 Kalisz, Poland"},{"name":"OVIklinika Infertility Center, 01-377 Warsaw, Poland"},{"name":"Department of Obstetrics, Gynecology and Gynecological Oncology, Medical University of Warsaw, 03-242 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,10,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1093\/humupd\/dmag011","article-title":"Endometriosis and ovarian cancer: Epidemiological evidence, molecular insights, and clinical decision-making","volume":"32","author":"Vignali","year":"2026","journal-title":"Hum. Reprod. Update"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.jmig.2026.04.021","article-title":"Risk, Prevalence and Survival Outcomes of Ovarian Cancer in Women with Endometriosis: The ENDOCANCER Systematic Review and Meta-Analysis","volume":"33","author":"Piacenti","year":"2026","journal-title":"J. Minim. Invasive Gynecol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ygyno.2026.05.004","article-title":"Endometriosis and ovarian cancer risk","volume":"209","author":"Bogani","year":"2026","journal-title":"Gynecol. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1001\/jama.2024.9210","article-title":"Endometriosis Typology and Ovarian Cancer Risk","volume":"332","author":"Barnard","year":"2024","journal-title":"JAMA"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1111\/aogs.70223","article-title":"Risks of gynecological and breast cancers in women with endometriosis or adenomyosis: A nationwide cohort study","volume":"105","author":"Moberg","year":"2026","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"101634","DOI":"10.1016\/j.ijgc.2025.101634","article-title":"Two possible entities of endometriosis-associated ovarian cancer: Correlated or incidental?","volume":"35","author":"Mezzapesa","year":"2025","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Beck, M.H., Kordowitzki, P., Roser, E., Trelinska-Finger, A., Schoof, E., Chinczewski, L., Mechsner, S., and Sehouli, J. (2026). Characteristics and outcomes of patients with endometriosis and malignant or borderline ovarian tumors: Real-world evidence from an ESGO centre of excellence. BMC Cancer, 26.","DOI":"10.1186\/s12885-026-15980-w"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.tjog.2025.11.029","article-title":"Platinum sensitivity drives prognosis in endometriosis-associated ovarian carcinoma compared with high-grade serous ovarian carcinoma: Insights from a 10-year retrospective study","volume":"65","author":"Sung","year":"2026","journal-title":"Taiwan. J. Obstet. Gynecol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2583543","DOI":"10.1080\/07853890.2025.2583543","article-title":"TCGA molecular subtypes in endometriosis-associated ovarian cancer: A systematic review and meta-analysis","volume":"57","author":"Ye","year":"2025","journal-title":"Ann. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"218845","DOI":"10.1016\/j.canlet.2026.218845","article-title":"Endometriosis from initiation to innovation: Immune microenvironments, clonal lesion biology, and the emerging therapeutic pipeline","volume":"660","author":"Santhamma","year":"2026","journal-title":"Cancer Lett."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Umezaki, Y., Okuma, R., Fukuda, A., Kamishita, Y., Kurihara, M., Satomi, Y., and Okugawa, K. (2026). A coupled iron-hypoxia selection model for the evolution of endometriosis-associated ovarian clear cell carcinoma. Front. Oncol., 16.","DOI":"10.3389\/fonc.2026.1965365"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"103034","DOI":"10.1016\/j.tranon.2026.103034","article-title":"Compartment-specific inflammation-metabolism remodeling across eutopic and ectopic endometriosis tissues with cross-context evaluation in TCGA-UCEC","volume":"73","author":"Yang","year":"2026","journal-title":"Transl. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s10142-026-02047-z","article-title":"Integrative analysis and experiment validation of SLC12A8 as a biomarker for the malignant transition from endometriosis to endometriosis associated ovarian cancer","volume":"26","author":"Dou","year":"2026","journal-title":"Funct. Integr. Genom."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Szubert, M., Gabriel, I., Rycerz, A., Goli\u0144ska, M., and Wilczy\u0144ski, J.R. (2026). MicroRNA Expression Profile in Endometriosis and Endometriosis-Associated Ovarian Cancer\u2014Systematic Review. Cells, 15.","DOI":"10.3390\/cells15040374"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Kordowitzki, P., Ying, K., Beck, M.H., Voltolini Velho, R., Engelbrecht, C., Sehouli, J., and Mechsner, S. (BMC Med., 2026). Multimodal analysis reveals asynchronous aging dynamics between endometriosis-associated ovarian cancer and endometriosis patients, BMC Med., in press.","DOI":"10.1186\/s12916-026-05101-6"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1001\/jama.2024.21905","article-title":"Endometriosis and Ovarian Cancer","volume":"332","author":"Terry","year":"2024","journal-title":"JAMA"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1001\/jama.2024.21908","article-title":"Endometriosis and Ovarian Cancer","volume":"332","author":"Vercellini","year":"2024","journal-title":"JAMA"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1001\/jama.2024.21911","article-title":"Endometriosis and Ovarian Cancer\u2014Reply","volume":"332","author":"Schliep","year":"2024","journal-title":"JAMA"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/jnci\/djaa163","article-title":"Long-Term Risk of Ovarian Cancer and Borderline Tumors After Assisted Reproductive Technology","volume":"113","author":"Spaan","year":"2021","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/humupd\/dmaa045","article-title":"Endometriosis and cancer: A systematic review and meta-analysis","volume":"27","author":"Kvaskoff","year":"2021","journal-title":"Hum. Reprod. Update"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1056\/NEJMoa1614814","article-title":"Cancer-Associated Mutations in Endometriosis without Cancer","volume":"376","author":"Anglesio","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Sorrentino, F., Nappi, L., Vona, L., Vasciaveo, L., Campitiello, M.R., Vitrani, P., Taurino, G., Tinelli, R., and Grandone, E. (2026). From Endometriosis to Endometriosis-Associated Ovarian Cancer: Molecular Mechanisms, Risk Stratification and Clinical Implications. Cancers, 18.","DOI":"10.3390\/cancers18081233"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/AOG.0000000000002624","article-title":"Risk of Gynecologic Cancer According to the Type of Endometriosis","volume":"131","author":"Saavalainen","year":"2018","journal-title":"Obstet. Gynecol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00428-011-1169-8","article-title":"PIK3CA mutations and loss of ARID1A protein expression are early events in the development of cystic ovarian clear cell adenocarcinoma","volume":"460","author":"Yamamoto","year":"2012","journal-title":"Virchows Arch."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"6118","DOI":"10.1038\/ncomms7118","article-title":"Coexistent ARID1A\u2013PIK3CA mutations promote ovarian clear-cell tumorigenesis through pro-tumorigenic inflammatory cytokine signalling","volume":"6","author":"Chandler","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Ioannidou, A., Sakellariou, M., Sarli, V., Panagopoulos, P., and Machairiotis, N. (2025). New Evidence About Malignant Transformation of Endometriosis\u2014A Systematic Review. J. Clin. Med., 14.","DOI":"10.3390\/jcm14092975"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Sohel, H.I., Kiyono, T., Zahan, U.F., Razia, S., Ishikawa, M., Yamashita, H., Kanno, K., Sonia, S.B., Nakayama, K., and Kyo, S. (2025). Establishment of a Novel In Vitro and In Vivo Model to Understand Molecular Carcinogenesis of Endometriosis-Related Ovarian Neoplasms. Int. J. Mol. Sci., 26.","DOI":"10.20944\/preprints202502.0858.v1"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1093\/humrep\/deae043","article-title":"Genomic alterations in ovarian endometriosis and subsequently diagnosed ovarian carcinoma","volume":"39","author":"Linder","year":"2024","journal-title":"Hum. Reprod."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1093\/humrep\/dep175","article-title":"Expression of selected tumor suppressor and oncogenes in endometrium of women with endometriosis","volume":"24","author":"Laudanski","year":"2009","journal-title":"Hum. Reprod."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ejogrb.2013.10.007","article-title":"Profiling of selected angiogenesis-related genes in proliferative eutopic endometrium of women with endometriosis","volume":"172","author":"Laudanski","year":"2014","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.cpan.2024.12.001","article-title":"Emerging trends and hot topics in the application of multi-omics in drug discovery: A bibliometric and visualized study","volume":"21","author":"Wang","year":"2024","journal-title":"Curr. Pharm. Anal."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1477-7827-11-78","article-title":"MicroRNAs expression profiling of eutopic proliferative endometrium in women with ovarian endometriosis","volume":"11","author":"Laudanski","year":"2013","journal-title":"Reprod. Biol. Endocrinol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Wr\u00f3bel, M., Zieli\u0144ska, Z., O\u0142dak, \u0141., Kalicka, A., Ma\u0144ka, G., Kiecka, M., Spaczy\u0144ski, R.Z., Piekarski, P., Banaszewska, B., and Jakimiuk, A. (2023). Evaluation of Proteasome and Immunoproteasome Levels in Plasma and Peritoneal Fluid in Patients with Endometriosis. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241814363"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"hoac009","DOI":"10.1093\/hropen\/hoac009","article-title":"ESHRE guideline: Endometriosis","volume":"2022","author":"Becker","year":"2022","journal-title":"Hum. Reprod. Open"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/19\/3241\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T08:29:37Z","timestamp":1791880177000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/19\/3241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,8]]},"references-count":34,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["cancers18193241"],"URL":"https:\/\/doi.org\/10.3390\/cancers18193241","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,8]]}}}